[Media Report] Good Future attacks preventive medicine and uses automated detection to detect cancer cells

Good Future Operations Director Hong Weishan (from left), Chang Gung Memorial University Professor Zeng Qingping from the Department of Medical Technology, and Inventec Appliances Medical Electronics Business Operations Manager Zeng Qingan. Reporter Xie Baihong/Photography

Inventec Appliances, a major electronics manufacturer with more than 26,000 employees around the world, chose to cooperate with a new start-up company Good Future in order to enter the biomedical field to jointly develop the most advanced cancer screening automation system in Taiwan. Good Future, this small company located in Guishan, Taoyuan, is ushering in a new era of cancer medical testing in Taiwan. (Extended reading: Good Future’s exclusive technology can screen 80% of tumors) On December 1 last year, Inventec Appliances and Good Future, after three years of cooperation, won the “17th National Innovation Award” in the Biopharmaceutical and Precision Medicine Category of the Enterprise Startup Group with an automated detection system named “IronMag®circulating tumor cells”.

Inventec Appliances is a subsidiary of Inventec Group (2356), the first brand of handheld electronic products in the Chinese world. Its "OKWAP" products have always been famous for their innovation and beauty in the market, covering various possible needs for network communication in the entire Greater China market. But the outside world is very curious, why did Inventec Appliances enter the field of cancer precision medical testing? What kind of company is Good Future that cooperates with Inventec Appliances?

Innovative approaches to make costs more affordable

Inventec Appliances Deputy General Manager Zeng Qing'an said that the group's development strategy in the biomedical field in recent years has focused on the three major fields of "smart medical care", "cloud health management" and "precision medicine". The first two products developed are the "Family Pal" physiological measurement system and the second "TTSmart" Zhihui infusion system. Both of them are developed independently. The third "precision medicine" part is through the cooperation with Good Future.

Zeng Qing'an said that "Family Pal" is a comprehensive physiological measurement system launched early last year; "TTSmart" smart infusion pump combines medical Internet technology with the purpose of assisting medical staff to complete infusion for patients more accurately, providing safety and simplicity.

As for the "IronMag®circulating tumor cells automatic detection system" cooperated by Inventec Appliances and Good Future, it is a set of automated equipment for cancer detection, a technology developed by the research team of Zeng Qingping, a professor at the Department of Medical Technology of Chang Gung Memorial University. The so-called "circulating tumor cells (circulating tumor cells, CTC)" means that cancer cells break off from the primary or early metastasis site and enter the blood vessels, and then further migrate to more parts of the body through blood circulation. A larger number of CTCs usually means the cancer is more severe.

Good Future Operations Director Hong Weishan said that among cancer types, 80 to 90% of cells are epithelial cell cancers. For example, lung cancer, breast cancer, and colorectal cancer are the most common epithelial cell cancers. Good Future is extracted from the blood of the human body to detect epithelial cell cancers circulating in the body.

Inventec Appliances cooperated with Good Future to develop "IronMag®circulating tumor cells automated detection system" and won the 17th National Innovation Award. Good Future／Provided

Target business opportunities and expand mainland territory

Inventec Appliances cooperates with Good Future to develop an automated testing system using CTC as the testing project. Zeng Qingping explained that currently, it often takes several days to test CTC in medical institutions or laboratories from the time the sample is obtained to the release of the test report. However, through Good Future's automated system, eight case tests can be completed in one day, and only 2cc of blood can detect 80% of cancer cells.

In 2017, Inventec Appliances, a subsidiary of Inventec Group, inadvertently learned about Zeng Qingping's technical principles in order to find suitable cancer detection technology. It can convert CTC detection from manual to fully automatic detection. Not only can the detection time be shortened, but the detection cost can also be significantly reduced, from 30,000 yuan per time to half.

However, many medical centers in China currently have CTC detection functions. The "IronMag®circulating tumor cells automatic detection system" jointly launched by Inventec Appliances and Good Future, compared with other detection systems, what are the functional differences? Hong Weishan explained that the CTC tests currently conducted by various medical centers adopt a "forward screening" mechanism, which is to find possible cancer cells in the blood. The accuracy is low and the possibility of false negatives (cancer is present but not found) is high. However, Inventec Appliances and Good Future have developed a "negative screening" mode detection system. Through the elimination method, the process of lysing red blood cells and removing white blood cells, and then identifying CTC functional markers, can more accurately calculate and capture cancer cells.

This CTC detection system has been approved by two large medical centers in the north and has been purchased by the medical center. Zeng Qing'an emphasized that since various medical institutions in mainland China are also very popular for cancer detection, this system will also begin to develop into the mainland market. It has obtained a mainland patent, and business opportunities to open up the international market for precision medicine are just around the corner.

Good FutureSmall file

Capital amount: 20.25 million yuan

Products and Services:

Competitive advantage: The only circulating tumor cells fully automated testing system on the market, capable of completing eight specimen tests in eight hours a day

Source----

United News Network